The ELLDOPA study is a controlled clinical trial in patients with newly diagnosed PD to determine the optimal timing and dosing with levodopa (Sinemet or its generic equivalents).
No linked publications found in PubMed
Inclusion Criteria: * Early, mild PD, not requiring medications * Age 30 or older * Duration from time of diagnosis of PD: less than 2 years * Hoehn \& Yahr Stage 1 or 2 * Exposure to levodopa or dopamine agonist of 14 days or less